RSS Feeds
Search

Companies

Innovaro Pharmalicensing

Innovaro Pharmalicensing
Innovaro Pharmalicensing.com - the leading global resource for partnering, licensing, and business development.

The company in detail

Profile

Innovaro Pharmalicensing is the leading global resource for partnering, licensing, and business development within the life science and biopharmaceutical industries. Our unique services complement and enhance business development activity throughout the deal-making process - from finding the perfect partner to closing the deal.

Licensing

For licensors - we help innovators market their licensing opportunities to decision makers at licensee organisations worldwide, including bigpharma, biotech companies, spin-offs and academic institutions.

For licensees - we facilitate global pharmaceutical/ biotechnology companies, investors, and research organisations in identifying, tracking and securing of technology opportunities, actively communicating licensing needs, and forming better partnerships.

In addition, we offer a comprehensive partner search, providing clients with a bespoke prospect list of partner search companies entirely based on their partnering criteria. Following client approval this prospect list can then be converted to a ‘hot list' where we will actively introduce our clients, using the Innovaro Pharmalicensing name, to one another to begin initial discussions.

For outsourced service providers - we market service providers, their skills and expertise to decision makers in pharmaceutical/biotechnology companies worldwide. This industry is becoming increasingly reliant on the expertise of third parties, in order to reduce the time to market and provide access to know-how worldwide.

Innovaro Pharmalicensing provides a unique approach to business development:

  • Access to the largest business development community
  • A broadcasting platform used by over 190, 000 users per month
  • Direct to potential business partners
  • Comprehensive access to business intelligence resources

Listing industry news, timely biopharma reports and details of forthcoming licensing and partnering events, Innovaro Pharmalicensing provides its users with the relevant mix of intelligence they require in order to strengthen and progress their business development activities further.

Out-licensing

Our client is an academic institution that has developed a unique anti-microbial monocaprin emulsion with key cleaning solvent properties indicated primarily for the preparation and protection of food and cosmetics. More
This newly developed dose measuring technology comprises of a thin foil that dissolves readily in the mouth thereby administering the exact dosage of certain medications. More
Our clients have a patent available for acquisition or licensing for a novel preparation method of Rabeprazole in the EU and Turkey (excluding Portugal) More
Our client company has developed an innovative frozen lozenge technology designed to deliver pharmaceuticals and OTC products, which offers a new alternative administration method for paediatric and otherwise difficult to swallow therapeutics. More
Women’s health specialists have created a non invasive class IIa medical device for the successful control of stress related incontinence. More
The three-chamber ‘Combiflex’ lipid bag provides a key source of glucose, amino acid solutions and fat emulsions to patients and children over the age of 2 who are unable to administer nutrition through the oral or enteral route. More

In-licensing

Our client is a start up company that is looking for off patent generics indicated for oncology or respiratory disorders and innovative delivery platforms to which to incorporate them into. More
Seeking to identify finished oral drug delivery technologies to in-license or acquire from any geographical region. More
Our clients seek prescription products, medical devices and nutraceuticals focused in the following therapeutic areas: urology, pediatrics, ENT, dermatology, OBGYN, family medicine, obesity and rheumatoid arthritis. More

Press Releases

(5th Jan 2012) Tampa, FL -- (Business Wire) – January 5, 2012 – Innovaro, Inc (NYSE Amex: INV), a leading IP licensing and innovation services company, is pleased to announce that its client CUI Global, Inc. (formerly Waytronx) has completed the sale of selected patents More
More press releases

Related Reports

Contact details

Mr Mark McBride
Managing Director

Contact directly

Full contact list

Head office

Innovaro Pharmalicensing
A division of Innovaro Europe Ltd
Marlborough House, 1st Floor, Westminster Place
York Business Park
York
North Yorkshire
YO26 6RW
United Kingdom

Company figures

Formed: 1998

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2012 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us